Global Reach Unolab exports sterile ophthalmic and respiratory formulations to more than 50 countries, highlighting a proven international distribution network and potential for cross-border collaborations, partnerships, and contract manufacturing opportunities in new markets.

Capacity Leverage With a manufacturing capacity of 550 million doses in 2024 and a focus on single-dose sterile formats, there is an opportunity to target larger pharma players seeking scalable CDMO partners for high-volume ophthalmic and respiratory products.

Innovation Focus Strong commitment to innovation and flexible, customer-centric service positioning Unolab as a preferred partner for complex sterile formulations, enabling upsell of specialized manufacturing services and process improvements.

Tech Enablement Existing tech stack and Bottelpack technology from Rommelag indicate a capability for advanced packaging and regulatory-friendly sterile solutions, suggesting opportunities to collaborate on FDA/EMA-compliant programs and expedited development cycles.

Strategic Partners Experienced CDMO with over 20 years in the field and a mid-size team (150+ professionals) positions Unolab as a reliable ally for tier-1 clients seeking dependable supply, quality assurance, and responsive project management in ophthalmic and respiratory spaces.